The purpose of this study is to evaluate the efficacy and safety of TAC-302 in detrusor underactivity patients with overactive bladder.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes in the Mean BCI for Male From Baseline to Week 12
Timeframe: Baseline to Week 12
Changes in the Mean PIP1 for Female From Baseline to Week 12
Timeframe: Baseline to Week 12